For ophthalmic use only. Instill one drop into the conjunctival sac of the affected eye(s). If more than one topical ophthalmic drug is being used, the drugs should be administered at least five minutes apart. Avoid contact with the dropper tip to prevent contamination.

Zultan (Latanoprost) reduces intraocular pressure by increasing the outflow of aqueous humor, primarily through the uveoscleral pathway and to a lesser extent through the trabecular meshwork.

• •Known hypersensitivity to Latanoprost or any other ingredient in Zultan eye drop

Store unopened bottles in a refrigerator (2°C to 8°C). Protect from light. After opening, store at room temperature (up to 25°C) and discard after 4 weeks.

Ocular overdose with Zultan (Latanoprost) is unlikely to occur with ophthalmic administration. If accidental ingestion occurs, symptomatic treatment may be required. The most common ocular side effects observed with higher dosages are conjunctival hyperemia and ocular irritation.

Pregnancy Category C. Should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is unknown whether Latanoprost and its metabolites are excreted in human milk; use with caution in nursing mothers.